Abstract:Sulfur dioxide (SO 2 ), long considered to be a harmful atmospheric pollutant, has recently been posited as the fourth gasotransmitter, as it is produced endogenously in mammals and has important pathophysiological effects. The field of tumor therapy has witnessed a paradigm shift with the emergence of SO 2 -based gas therapy. This has been possible because SO 2 is a potent glutathione consumer that can promote the production of reactive oxygen species, eventually leading to oxidative-stress-induced cancer cell death. Nevertheless, this therapeutic gas cannot be directly administrated in gaseous form. Thus, various nano formulations incorporating SO 2 donors or prodrugs capable of storing and releasing SO 2 have been developed in an attempt to achieve active/passive intratumoral accumulation and SO 2 release in the tumor microenvironment. In this review article, the advances over the past decade in nanoplatforms incorporating sulfur SO 2 prodrugs to provide controlled release of SO 2 for cancer therapy are summarized. We first describe the synthesis of polypeptide SO 2 prodrugs to overcome multiple drug resistance that was pioneered by our group, followed by other macromolecular SO 2 prodrug structures that self-assemble into nanoparticles for tumor therapy. Second, we describe nanoplatforms composed of various small-molecule SO 2 donors with endogenous or exogenous stimuli responsiveness, including thiol activated, acid-sensitive, and ultraviolet or near-infrared light-responsive SO 2 donors, which have been used for tumor inhibition. Combinations of SO 2 gas therapy with photodynamic therapy, chemotherapy, photothermal therapy, sonodynamic therapy, and nanocatalytic tumor therapy are also presented. Finally, we discuss the current limitations and challenges and the future outlook for SO 2 -based gas therapy. Statement of Significance : Gas therapy is attracting increasing attention in the scientific community because it is a highly promising strategy against cancer owing to its inherent biosafety and avoidance of drug resistance. Sulfur dioxide (SO 2 ) is recently found to be produced endogenously in mammals with important pathophysiological effects. This review summarizes recent advances in sulfur dioxide (SO 2 ) releasing nanosystems for cancer therapy, including polymeric prodrugs, endogenous or exogenous stimulus-activated SO 2 donors delivered by nanoplatform and combination therapy strategies.

Gas Therapy: an Emerging "green" Strategy for Anticancer Therapeutics

Nanotechnology based gas delivery system: a "green" strategy for cancer diagnosis and treatment

Gas-mediated cancer therapy

Novel Gas‐based Nanomedicines for Cancer Therapy

Nanotherapeutics for Hydrogen Sulfide-Involved Treatment: an Emerging Approach for Cancer Therapy

Gas-mediated cancer therapy combined with starvation therapy, ultrasound therapy, chemotherapy, radiotherapy, and photodynamic therapy: a review

Recent Progress in Bioactive Gas Delivery for Cancer Immunotherapy

Current trends in gas-synergized phototherapy for improved antitumor theranostics

Gas-assisted phototherapy for cancer treatment

Gas Therapy: Generating, Delivery, and Biomedical Applications

Gas immnuo-nanomedicines fight cancers

The Advancement of Gas‐Generating Nanoplatforms in Biomedical Fields: Current Frontiers and Future Perspectives

Recent Advances in Sulfur Dioxide Releasing Nanoplatforms for Cancer Therapy

Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer

Photoregulated plasmon enhanced controllable hydrogen sulfide delivery for photothermal augmented gas therapy

Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy

Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy

Recent advances in the development of metal–organic framework-based gas-releasing nanoplatforms for synergistic cancer therapy

A multi-parameter-induced activation of gas therapeutic platform to remarkably amplify photodynamic therapy efficacy

Gaseous Signaling Molecule-Releasing Hybrid Nanomaterials for Therapeutic Applications

Emerging Delivery Strategies of Carbon Monoxide for Therapeutic Applications: from CO Gas to CO Releasing Nanomaterials